{"disease":{"id":"nonseminomatous-germ-cell-tumor","name":"nonseminomatous germ cell tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06967961","title":"Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false},{"nct_id":"NCT05108298","title":"Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Eastern Cooperative Oncology Group","has_results":false},{"nct_id":"NCT06133543","title":"Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT02689219","title":"Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Nabil Adra","has_results":true},{"nct_id":"NCT05634785","title":"CD30 CAR for CD30+ NSGCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}